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INTRODUCTION:  The  objective  is to report a  rare  tumour  of  the  sinonasal  tract  and conduct  a literature
review.
Malignant  triton  tumour  is  a subtype  of  malignant  schwannoma  with  rhabdomyoblastic  differentiation.
It  is  a very  rare  tumour,  with  only  15  reported  cases  involving  the  sinonasal  region.
PRESENTATION  OF  CASE:  Forty-seven  years  old female  presented  with  a right-sided  epistaxis,  progressive
right  sided  nasal  obstruction  and  anosmia  and  a visible  mass  in  the right  nasal  cavity.  Imaging  studies
showed  a  mass  extending  from  the  piriform  aperture  to  the  nasopharynx  in  contact  with  the  dura  and
the  orbital  content.  The  mass  was  biopsied  and the result  was  consistent  with  malignant  triton  tumour.
The  patient  refused  the surgery  at ﬁrst  so  chemotherapy  with  MAID  protocol  was started.  After  the fourth
course  of  chemotherapy  the  treatment  was stopped  due  to  patient  intolerance  and  a  thrombosis  of  the
jugular  vein.  Patient  then  underwent  surgery  with  frontal  craniotomy  and dural  excision,  endoscopic
control  was  done  at  the  end  to  insure  a  complete  removal.  The  patient  received  Radiotherapy  in  the
postoperative  period  (56  Greys).  At 5 years  of follow  up  the  patient  is doing  ﬁne  with  no  signs  of  recurrence
and  normal  ophthalmological  ﬁndings.
DISCUSSION:  Sixteen  cases,  including  our  case, have been  reported  to  date  in the  literature.  The  mean
age  at  presentation  is  61  years.  None  of  cases  were  associated  with  neuroﬁbromatosis  type  1.  Eight
patients  were  reported  to be alive  5 years  post-treatment,  and  2 patients  were  reported  to have  died  of
the  disease.  The  prognosis  for triton  tumours  in  the sinonasal  tract  is better than  that  for triton  tumours
in  other  locations.
CONCLUSION:  Malignant  triton tumour  is  a  rare  malignancy  of  the  sinonasal  tract.  Otolaryngologists
should be  aware  of  this  disease.  The  optimal  treatment  should  include  radical  resection  of  the tumour.
© 2014  The  Authors.  Published  by  Elsevier  Ltd. on behalf  of Surgical  Associates  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Malignant triton tumour is a subtype of malignant schwannoma
ith rhabdomyoblastic differentiation.1 To date, approximately
50 cases have been reported in the literature.2 Masson, in 1932,
as the ﬁrst to describe a malignant schwannoma with rhabdomy-
blastic differentiation in a patient with neuroﬁbromatosis type
(NF1).3
 This review was presented as an oral presentation at the 6th International
ongress of the World Federation of Skull Base Societies and the 10th European
kull Base Society Congress 2012 that occurred at the Brighton Hilton Metropole
rom 16–19 May  2012.
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210-2612/© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical A
http://creativecommons.org/licenses/by-nc-nd/3.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Malignant triton tumour is a very rare tumour that occurs in
head and neck region and the trunk, with almost one third of the
cases in the head and neck area.4 It can be associated with neuroﬁ-
bromatosis type one (NF1) (in patients younger than 35-years old)
or it can occur sporadically (in older patients). The patients with NF
1 have a poorer prognosis (Table 1).2
To the best of our knowledge, the sinonasal localisation was
reported in only 15 cases in the English and French literature.2,4–7
The aim of this article is to present a case with a rare malignancy of
the sinonasal tract and to describe a literature review of malignant
triton tumours in this speciﬁc anatomical location.2. Case report
A 49-year-old women  presented to the emergency department
in April 2005 with right-side epistaxis and a 2-year history of
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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Table 1
Review of the literature on malignant triton tumours of the sinonasal tract.
Patients Age/sex NF 1 Localisation Treatment Radio- or
chemotherapy
Retreatment Outcome
Shajrawi et al. [14] 75/M No Left paranasal sinuses Debulking RT Surgical removal of recurrence
at 36 months
Alive NED at 6 months
Bhatt  et al. [11] 66/F No Left nasal cavity Extended external
ethmoidectomy
Alive with tumour at 27
months
Heffner  and Gnepp [13] 64/M No Left nasal cavity Incomplete excision Died of tumour at 27 months,
pulmonary metastasis and
cranial extension
58/M  No Nasal cavity Surgery RT Alive NED at 48 months
56/F  No Left nasal cavity Local excision Removal of recurrence at 11
and 15 years
Alive NED at 7 years
59/M  No Right nasal cavity Transpalatal excision RT Alive NED at 7 years
43/M  No Right nasal cavity N/A Recurrence at 15 years,
treatment N/A
Alive NED at 7 years
Nicolai  et al. [5] 81/F No Right nasal cavity Endoscopic excision Alive NED at 36 months
Kim  et al. [4] 38/F No Right nasal cavity Medial maxilectomy RT Alive NED at 5 years
Tringali  et al. [6] 80/F N/A Right nasal cavity Extended midfacial resection Recurrence at 8 months with
cerebral involvement,
midfacial and sub frontal
excision and RT. 3 endoscopic
partial resections in 5 years
Alive with disease at 5 years
Xue  et al. [7] 47/F N/A Right paranasal sinuses Lateral rhinotomy RT Alive NED at 5 years
Terzic  et al. [2] 35/F no Right nasal cavity Craniotomy with sub-cranial
resection
Alive NED at 30 months
77/M  No Left nasal cavity Partial endoscopic resection RT for lymph node metastasis
at 6 months
Alive with tumour at 7.5
months
73/F  No Right maxillary sinus Partial endoscopic resection Endoscopic resection with RT
for recurrence at 18 months
Died of other causes at 5.5
years
76/M  no Left sinonasal CAVITY Refused treatment Died of tumour at 1.5 months
Present  case 49/F N/A Right nasal cavity Craniotomy with sub-cranial
resection
RT Alive NED at 5 years
N/A: not available or not speciﬁed, NED: no evidence of disease, RT: radiotherapy.
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Fig. 1. (a) Preoperative MRI  (T1 sequence with gadolinium injection) showing the
tumour in the right nasal fossa with intracranial extension with mass effect on the
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quent endoscopic partial removals), and one patient was treatedrbit. (b) Post operative MRI  (T2 sequence with gadolinium injection) at 5 years
howing no evidence of tumour recurrence.
rogressive right-side nasal obstruction and anosmia, and a visible
ass in the right nasal cavity. The rest of the history and physi-
al examination revealed a history of meningitis and respiratory
uberculosis in infancy and a caesarean section. She had normal
eurological and ophthalmological exams and no cutaneous lesions
r lymph node enlargement.
CT and MRI  scans were conducted, which showed a lesion occu-
ying the right nasal fossa with maxillary sinus involvement that
xtended from the piriform aperture to the cavum and was in con-
act with the orbital contents (absence of the lamina papyracea)
nd the dura in the region of the cribriform plate (Fig. 1).PEN  ACCESS
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Because several different types of malignancy were possible
(rhabdomyosarcoma, neuro-endocrine tumour, neuroblastoma,
and chordoma), a biopsy was  performed under local anaesthesia
during her hospitalisation; however, the histological ﬁndings were
inconclusive. Therefore, another biopsy was  performed under gen-
eral anaesthesia, and the biopsy sample was sent to the central
histopathology department in France (Hospital Lariboisere).
The microscopic examination showed a very cellular tumour
containing spindle-shaped cells with oval and comma  shaped
nuclei. Eosinophilic cytoplasm was also observed. This aspect was
associated with well-differentiated muscle fascicles with a very low
mitotic index (1 mitosis per 10 high-power ﬁelds).
Immunohistochemistry showed that the tumour cells were
immuno-stained for S-100 protein and vimentin ﬁlaments, sug-
gesting a Schwann cell origin. Therefore, the diagnosis of a nerve
sheath tumour with rhabdomyoblastic differentiation was reached.
Testing for NF 1 was not performed because the patient was  more
than 60 years old and did not have any other features of the disease.
The patient refused surgery at that time, so she began
chemotherapy using the MAID protocol (Mesna, doxorubicin, ifos-
famide, and dacarbazine); however, after the fourth course, the
treatment was stopped because of the patient’s lack of tolerance
and because a thrombosis of the jugular vein over the central line
had developed (Fig. 2).
The patient again refused the surgical option. However, three
months later, the patient presented to the hospital with right
exophthalmia and new MRI  and CT scans were performed. The
tumour was  observed to be in contact with the orbital contents
and the frontal dura with no evidence of metastasis or cerebral
invasion.
The oncological multidisciplinary team proposed surgical
treatment with neurosurgical collaboration, followed by three-
dimensional radiotherapy.
In September 2006, the surgery was performed via a frontal
craniotomy. The tumour was removed along with the septum,
lamina papyracea, and middle turbinate, and dural excision and
duraplasty was performed by the neurosurgical team. An endo-
scopic nasal evaluation was conducted at the end of the procedure
to ensure complete tumour removal. The patient was discharged
on day 7 with no complications (no dural invasion was observed
on histopathology).
Subsequently, radiotherapy was conducted on the tumour site
only (56 Greys).
The patient is alive at 5 years post-treatment with no signs of
recurrence and normal ophthalmological ﬁndings.
3. Results
Of the 16 cases reported to date in the literature, the mean age
at presentation is 61 years (range: 38–81) with a slight female pre-
dominance 1.3:1(9:7) and a right-side predominance 1.6:1(10:6).
Eight of the 16 patients were reported to be alive at 5 years
post-treatment, 7 without evidence of disease and one with dis-
ease progression. Two patients were reported to have died of the
disease, one with pulmonary metastasis and cranial extension and
one patient who  refused all treatment. One patient was  reported to
have neck lymph-node metastases.
Seven patients (43%) had recurrence, of which ﬁve had incom-
plete excision or non-radical excision. In the other 2 cases, the
surgical details were not speciﬁed. Two patients were treated
with surgery and radiotherapy (one underwent three subse-with radiotherapy alone for lymph-node metastases. Two  of the
patients were retreated with surgery alone, with one of these two
patients undergoing 2 surgeries. In one patient, the retreatment
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Fig. 2. Photo 1: immunohistochemical analysis showing focal positive Ps 100 staining (indicating a nerve sheet origin) with scattered spindle cells (IHC ×40). Photo 2:
immunohistochemical analysis showing strong focal positive myogenin staining (indicating a striated muscle cells IHC ×25). Photo 3: immunohistochemical analysis showing
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ltrong  positive desmine staining (indicating a striated muscle cells IHC ×10). Photo
 mesenchymal cells IHC ×40).
as not speciﬁed, and another patient underwent no retreatment
nd subsequently died from pulmonary metastases and cerebral
nvolvement.
The overall survival of patients with malignant sinonasal triton
umour at 5 years is 50%.
Statistical analysis was limited by the small sample size and the
imited duration of follow up.
. Discussion
Malignant schwannoma with rhabdomyoblastic differentiation
s a rare malignancy that is referred to as malignant triton tumour.
he term, malignant triton tumour, was ﬁrst used by Woodruff to
escribe such lesions,1 and the name refers to Locatelli’s experi-
ent in 1925 in which a supranumerary limb growth with muscles
nd bone occurred in the triton salamander after implanting a sci-
tic nerve on it’s back.8
To date, only approximately 150 cases have been reported, with
3 arising in the head and neck area2 and very few in the sinonasal
rea. However, it appears that this ﬁgure is an underestimation of
he actual number due to the unclear description of the cases or
abelling the tumour as a malignant schwannoma. The pathologistmunohistochemical analysis showing strong positive vimentin staining (indicating
plays an important role in establishing the diagnosis, and it can be
difﬁcult in some cases, such as the one that presented here, because
our pathologist could not reach a speciﬁc diagnosis. The specimen
was sent to the central histopathology department of the country
where an experienced pathologist made the diagnosis. There were
2 months between the ﬁrst biopsy and the diagnosis, which is a
long time for such a malignancy.
The original histological criteria for establishing the diagnosis of
the malignant triton tumour was  proposed by Woodruff in 19731;
the criteria require that the tumour
1. Arise along the course of a peripheral nerve in a patient with
NF-1.
2. Display most of the growth characteristics of Schwann cells.
3. Contain bona ﬁde rhabdomyoblasts.
Various rates of association between malignant triton tumours
and NF-1 have been reported in the literature (23–69%)1,2,4,9–11: the
largest series of head and neck localised malignant triton tumours
was reported by Terzic in 20094 and included 53 patients of which
only 23% were found to be NF-1 positive. In the current review
of all of the patients with sinonasal tract localisation, none had
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F-1, which is the same result reported by Nicolai.5 Although in
ur case, the NF-1 test was not performed because there were no
linical features suggestive of NF-1 and the patient’s was  above 35
ears old. In another two cases, the NF-1 status was not speciﬁed,
ringing the total cases of malignant triton tumours localised in
he sinonasal tract that were conﬁrmed NF-1 negative to 13 of the
6 cases.
In the 16 cases of sinonasal tumour localisation, the mean age is
1 (38–81), which is slightly older than the age reported for patients
ith head and neck tumour localisation (40 years) or patients with
F-1 (26 years).2
Malignant schwannoma with rhabdomyoplastic differentiation
s much more aggressive than sporadic schwannoma,10 with an
verall 5-year survival rate of 12%10 for patients with malignant
chwannoma tumours in all locations and approximately 26%12 for
atients with the tumours in the head and neck area. However,
erzic recently reported a 5-year survival rate of 49% for patients
ith malignant triton tumours in the head and neck2 Tumours
ocalised to the sinonasal tract seem to have a more favourable
rognosis than tumours localised elsewhere.2,5,13,14 Our result is
onsistent with Terzic’s report because we observed an overall 5-
ear survival rate of 50%. This results might be due to the lower
rade histology of the sinonasal tract tumours compared to that
f tumours localised elsewhere, as in our case and as reported by
hatt11 and Nicolai.5
There is no consensus regarding the treatment guidelines for
alignant triton tumours. Various recommendations have been
roposed by several authors, including radical excision15,16 rad-
cal excision followed by radiotherapy and chemotherapy10,17–20
r excision and radiotherapy4,5,12. However, as for any other sar-
oma, resection of the tumour with wide margins followed by
adiotherapy is the recommended treatment, whereas the need for
hemotherapy has not been clearly deﬁned.12
. Conclusion
We  presented the sixteenth case of a malignant triton tumour
f the sinonasal tract. This is a rare tumour that has a different
roﬁle than malignant triton tumours localised elsewhere because
t presents in older patients, is not associated with NF1, and has a
ow histological grade in general. However, intracranial extension
nd metastasis of malignant triton tumours have been reported.
adical excision with wide margins followed by radiotherapy is
he recommended treatment.
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